Integrated Phosphoproteomics for Identifying Substrates of Human Protein Kinase A (PRKACA) and Its Oncogenic Mutant DNAJB1

Integrated Phosphoproteomics for Identifying Substrates of Human Protein Kinase A (PRKACA) and Its Oncogenic Mutant DNAJB1–PRKACA

Published:2021-08-26 Issue:10 Volume:20 Page:4815-4830
ISSN:1535-3893
Container-title:Journal of Proteome Research
language:en
Short-container-title:J. Proteome Res.

Author:

Karamafrooz Adak¹²,Brennan Jack³,Thomas David D.¹^ORCID,Parker Laurie L.¹^ORCID

Affiliation:

1. Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, Minnesota 55455, United States

2. Current affiliation: Department of Diabetes Complications and Metabolism, Beckman Research Institute, City of Hope, Duarte, California 91010, United States

3. Independent Technology Consultant, LIC, Boston, Massachusetts 02129, United States

Funder

National Cancer Institute

Publisher

American Chemical Society (ACS)

Subject

General Chemistry,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jproteome.1c00500

Reference44 articles.

1. Fibrolamellar hepatocellular carcinoma in the USA, 2000–2010: A detailed report on frequency, treatment and outcome based on the Surveillance, Epidemiology, and End Results database

2. Fibrolamellar Carcinoma: 2012 Update

3. Fibrolamellar Hepatocellular Carcinoma: A Rare but Distinct Type of Liver Cancer

4. Detection of a Recurrent DNAJB1-PRKACA Chimeric Transcript in Fibrolamellar Hepatocellular Carcinoma

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Substrate Prediction for the TAM Family of RTKs Using Phosphoproteomics and Structure-Based Modeling;ACS Chemical Biology;2023-12-30

2. Novel substrate prediction for the TAM family of RTKs using phosphoproteomics and structure-based modeling;2023-09-03

3. Regulation of Transcriptional Activity of Merkel Cell Polyomavirus Large T-Antigen by PKA-Mediated Phosphorylation;International Journal of Molecular Sciences;2023-01-03

4. The cAMP-signaling cancers: Clinically-divergent disorders with a common central pathway;Frontiers in Endocrinology;2022-10-13